FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 329:1822 December 9, 1993 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Inhaled steroids are commonly used in the treatment of chronic asthma, partly because of their diminished systemic side effects as compared with systemic steroids¹. Irrespective of the route of administration, however, steroid use has been associated with both glaucoma and cataract formation². A substantial number of people have elevated intraocular pressure when treated with long-term topical or systemic glucocorticoids³. Although glaucoma is more common in certain populations (e.g., African Americans, Northern Europeans, and first-degree relatives of patients with glaucoma), it can also develop in people without risk factors³.

We have evaluated three patients . . . [Full Text of this Article]

References

This article has been cited by other articles:

• (1999). Inhaled glucocorticosteroids in adults and children. CMAJ 161: s24-28 [Full Text]